logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
R

Roberto Alonzi

Mount Vernon Cancer Centre
H指数:22
被引数:3,150

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Is it feasible to randomize between treatment with stereotactic body radiotherapy (SBRT) versus high dose rate brachytherapy (HDR BT)?

既往接受放疗的前列腺癌患者的再放疗方案（RO-PIP）：能否随机比较立体定向体部放疗（SBRT）与高剂量率近距离放疗（HDR BT）的治疗？

Clinical Oncology
IF3
2026-02-190
OAAI
Jim Zhong; Finbar Slevin; Sarah Brown; Maria Serra; Peter Bownes; Christopher Thompson; Rachel Reed; Kimberley Reeves; Michael Dubec; Cynthia Eccles; Robert Chuter; Yat Man Tsang; N.Jane Taylor; Catharine M.L. West; David Buckley; Roberto Alonzi; Andrew Scarsbrook; Ananya Choudhury; Peter Hoskin; Ann M. Henry
Radium-223 in metastatic castration-resistant prostate cancer: whole-body diffusion-weighted magnetic resonance imaging scanning to assess response

转移性去势抵抗性前列腺癌的镭223: 全身弥散加权磁共振成像扫描评估反应

JNCI CANCER SPECTRUM
IF4.1
2023-10-033
OAAI
Parker, Chris; Tunariu, Nina; Tovey, Holly; Alonzi, Roberto; Blackledge, Matthew D.; Cook, Gary J. R.; Chua, Sue; Du, Yong; Hafeez, Shaista; Murray, Iain; Padhani, Anwar R.; Staffurth, John; Tree, Alison; Stidwill, Helen; Finch, Jessica; Curcean, Andra; Chatfield, Peter; Perry, Sophie; Koh, Dow-Mu; Hall, Emma
Acute Toxicity of Hypofractionated and Conventionally Fractionated (Chemo)Radiotherapy Regimens for Bladder Cancer: An Exploratory Analysis from the RAIDER Trial
CLINICAL ONCOLOGY
IF3
2023-09-017
OAAI
Huddart, R.; Hafeez, S.; Omar, A.; Alonzi, R.; Birtle, A.; Cheung, K. C.; Choudhury, A.; Foroudi, F.; Gribble, H.; Henry, A.; Hilman, S.; Hindson, B.; Lewis, R.; Muthukumar, D.; Mclaren, D. B.; Mcnair, H.; Nikapota, A.; Olorunfemi, A.; Parikh, O.; Philipps, L.; Rimmer, Y.; Syndikus, I.; Tolentino, A.; Varughese, M.; Vassallo-Bonner, C.; Webster, A.; Griffin, C.; Hall, E.
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial

对新诊断的转移性前列腺癌 (STAMPEDE) 的原发肿瘤进行放射治疗: 一项随机对照3期试验

LANCET
IF88.5
2018-12-01912
OAAI
Parker, Christopher C.; James, Nicholas D.; Brawley, Christopher D.; Clarke, Noel W.; Hoyle, Alex P.; Ali, Adnan; Ritchie, Alastair W. S.; Attard, Gerhardt; Chowdhury, Simon; Cross, William; Dearnaley, David P.; Gillessen, Silke; Gilson, Clare; Jones, Robert J.; Langley, Ruth E.; Malik, Zafar I.; Mason, Malcolm D.; Matheson, David; Millman, Robin; Russell, J. Martin; Thalmann, George N.; Amos, Claire L.; Alonzi, Roberto; Bahl, Amit; Birtle, Alison; Din, Omar; Douis, Hassan; Eswar, Chinnamani; Gale, Joanna; Gannon, Melissa R.; Jonnada, Sai; Khaksar, Sara; Lester, Jason F.; O'Sullivan, Joe M.; Parikh, Omi A.; Pedley, Ian D.; Pudney, Delia M.; Sheehan, Denise J.; Srihari, Narayanan Nair; Tran, Anna T. H.; Parmar, Mahesh K. B.; Sydes, Matthew R.

研究方向

暂未获取到该数据
P
Peter Hoskin
H 指数:0论文数:8被引数:240
G
Gerry Lowe
H 指数:23论文数:86被引数:3,507
P
Peter Ostler
H 指数:29论文数:94被引数:5,274
R
Robert Hughes
H 指数:46论文数:175被引数:1.1万
A
Anwar R. Padhani
H 指数:99论文数:452被引数:3.6万
H
Hannah Tharmalingam
H 指数:10论文数:55被引数:306
Y
Y. Tsang
H 指数:25论文数:203被引数:2,730
P
Peter Hoskin
H 指数:98论文数:1,309被引数:4.3万
A
Ana M. Rojas
H 指数:42论文数:199被引数:7,132
A
Ananya Choudhury
H 指数:49论文数:635被引数:9,260